News
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- DNA
- Education
- End of Treatment
- Hartwig Medical Database
- Hartwig Medical Foundation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Research
- Scientific publications
- Uncategorized
- Whole genome sequencing
- Working in the cloud
ASCO 2021: Presentations about whole genome sequencing
At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk …
New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS
Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …
Measuring the effects of radiotherapy on cancer may open up avenues for treatment
Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …
Whole Genome Sequencing for cancer diagnostics clinically validated
Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …
In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands
This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to …
Dutch House of Representatives votes for action of the Minister for arranging (provisional) reimbursement for whole genome sequencing-based DNA testing for most urgent groups of cancer patients
On February 25 2021, the Dutch House of Representatives adopted a motion approving reimbursement on a provisional basis of a …
Antoni van Leeuwenhoek hospital brings comprehensive DNA test closer for all cancer patients
This year, Antoni van Leeuwenhoek hospital joined forces with Hartwig Medical Foundation to deploy the most comprehensive DNA test available …
Take a virtual tour of our laboratory: from the biopsy to the patient report
What happens to your tumor tissue and blood during a comprehensive DNA test? What exactly does all the complex equipment …
Accreditation renewed
In October 2020, we received formal notification of the renewal of our accreditation of ISO17025: 2005 into the 2017 version. We …
Patients can benefit from whole genome sequencing for immunotherapy
Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …
Whole Genome Sequencing feasible in clinical practice
Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …
SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found
At Hartwig we “analyse sequenced tumor DNA”. This is something we try to continuously improve. These analyses are shared with …
Blogs
Always an eye for privacy
While applying for this job, I was asked about my views on rules. Do I prefer to test the limits, …
Read moreThe big advantage of having Hartwig Medical Foundation data available in the cloud
I don’t remember exactly when I first heard about Hartwig Medical Foundation and the whole genome sequencing data it has …
Read moreVideos
From biopsy to patient report
The comprehensive DNA test can provide patients with cancer with more opportunities for treatment. Using the technique of Whole Genome …
Read moreWhat does Hartwig Medical Foundation do?
Hartwig Medical Foundation is a unique initiative that makes possible progress in the research of treatment of cancer in the …
Read moreThe number of WGS samples Hartwig Medical Foundation has is quite unique in the research field and is rapidly growing. It amounted to 3.500 samples when we started and it’s already over 5.000 now.